AIDS Psychiatry. Psychiatric and Palliative Care, and Pain Management.

AIDS and Other Manifestations of HIV Infection

Volumn , Issue , 2004, Pages 537-576

  Cohen, Mary Ann Adler ^a   Alfonso, César A ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942847813     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012764051-8/50021-4     Document Type: Chapter

References (394)

1. Cohen MA Biopsychosocial aspects of the HIV epidemic. AIDS and other manifestations of HIV infection 1992, 349-371. Raven Press, Ltd. 2nd ed. G.P. Wormser (Ed.).
2. Cohen MA, Weisman HW A biopsychosocial approach to AIDS. Psychosomatics 1986, 27:245-249.
3. Cohen MA Psychiatric aspects of AIDS: A biopsychosocial approach. AIDS and other manifestations of HIV infection 1987, 579-622. Noyes Publications, New York. 1st ed. G.P. Wormser, R.E. Stahl, E.J. Bottone (Eds.).
4. Hunter ND Epidemic of fear: A survey of AIDS discrimination in the 1980s and policy recommendations for the 1990s. American Civil Liberties Union AIDS Project 1990, ACLU, Park Ridge, N.J.
5. Blendon RJ, Donelan K Discrimination against people with AIDS: the public's perspective. N Engl J Med 1988, 319:1022-1026.
6. Cohen MA AID Sism, a new form of discrimination. AMA News 1989, 20:43. January.
7. Wormser GP, Joline C Would you eat cookies prepared by an AIDS patient? Survey reveals harmful attitudes among professionals. Postgrad Med 1989, 86:174-184.
8. Thompson LM Dealing with AIDS and fear: Would you accept cookies from an AIDS patient?. South Med J 1987, 80:228-232.
9. Kelly JA, St.Lawrence JS, Smith S, Hood HV, Cook DJ Stigmatization of AIDS patients by physicians. Am J Public Health 1987, 77:789-791.
10. Cohen MA A biopsychosocial approach to the human immunodeficiency virus epidemic. Gen Hosp Psychiatry 1990, 12:98-123.
11. Lipowski ZJ The holistic approach to medicine. Psychosomatic medicine and liaison psychiatry 1985, 105-117. Plenum Press, New York. Z.J. Lipowski (Ed.).
12. Engel GL The need for a new medical model: A challenge for biomedicine. Science 1977, 196:129-136.
13. Kimball CP The biopsychosocial approach to the patient 1987, Williams and Wilkins, New York.
14. Engel GL The biopsychosocial model and medical education: Who are the teachers?. N Engl J Med 1982, 306:802-805.
15. Cohen MA, Weisman HW, Vazquez C The acquired immunodeficency syndrome: A psychiatric crisis. NY Med Q 1988, 8:53-58.
16. Centers for Disease Control and Prevention. HIV/AIDS surveillance report: U.S. HIV and AIDS cases reported through June 2000-2001 12; 1-44.
17. Mann J, Tarantola DJM, Netter TW AIDS in the World: A global report 1992, 107. Harvard University Press, Baltimore.
18. Centers for Disease Control and Prevention Update: Mortality attributable to HIV infection among persons aged 25-44 years-United States 1994. MMWR 1996, 45:121-125.
19. Centers for Disease Control and Prevention HIV/AIDS surveillance report: U.S. AIDS cases reported through September 1993. MMWR 1996, 8:5-39.
20. De Vincenzi I A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994, 331:341-346. The European Study Group on Heterosexual Transmission of HIV.
21. Michaels D, Levine C Estimates of the number of motherless youth orphaned by AIDS in the United States. JAMA 1992, 268:3456-3461.
22. UNAIDS Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 2000.
23. Alfonso CA, Cohen MA, Aladjem AD, Morrison F, Powell DR, Winters RA, Owlowski BK HIV seropositivity as a major risk factor for suicide in the general hospital. Psychosomatics 1994, 35:368-373.
24. Gala C, Pergami A, Catalan J, Riccio M, Durbano F, Musicco M, Baldeweg T, Invernizzi G Risk of deliberate self-harm and factors associated with suicidal behaviors among asymptomatic individuals with human immunodeficiency virus infection. Acta Psychiatr Scand 1982, 86:70-75.
25. Perry S, Jacobsberg L, Fishman B Suicidal ideation and HIV testing. JAMA 1990, 263:679-682.
26. Gotoh T, Ajisawa A, Negishi M, Yamaguchi T A study of suicide and attempted suicide in HIV carriers and patients with AIDS. Xth International Conference on AIDS 1994, 400. (abst.).
27. McKegney FP, O'Dowd MA Suicidality and HIV status. Am J Psychiatry 1982, 149:396-398.
28. Erfurth A, Naber D, Goebel FD AIDS disease and psychopathology-observations by the psychiatric consultation service of an internal medicine clinic. Fortschr Neurol Psychiatry 1989, 57:173-469.
29. Woller W, Arendt G, Kruse J, Bostrom J, von Giessen HJ Prediction of suicidality in HIV-positive men. International Conference on AIDS 1993, 9:896. (abst.).
30. Van Haastrecht HJ, Mientjes GH, van den Hoek AJ, Coutinho RA Death from suicide and overdose among drug injectors after disclosure of first HIV test result. AIDS 1994, 8:1721-1725.
31. Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L Prevalence of psychiatric disorders in early stages of HIV infection. Psychosomatic Med 1992, 54:588-601.
32. Ayuso MJL, Lastra I, Montanes F Research in psychopathology in patients with HIV/AIDS and psychiatric services in Spain. AIDS Care 1996, 8:2.
33. Ayuso MJL, Lastra I, Montanes F Research in psychopathology in patients with HIV/AIDS and psychiatric services in Spain. AIDS Care 1996, 8:233-239.
34. Cohen MA Psychiatric care in an AIDS nursing home. Psychosomatics 1998, 39:154-161.
35. Lyketsos CG, Hanson A, Fishman M, McHugh PR, Treisman GJ Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Intl J Psychiatry Med 1994, 24:103-113.
36. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Cambridge. 4th ed.
37. Beckett A, Summergrad P, Manschreck T, Vitagliano H, Henderson M, Buttolph ML, Jenike M Symptomatic HIV infection of the CNS in a patient without clinical evidence of immune deficiency. Am J Psychiatry 1987, 144:1342-1344.
38. Jones HR, Ho DD, Forgacs P, Adelman LS, Silverman ML, Baker RA, Locuratolo P Acute fulminating fatal leukoencephalopathy as the only manifestation of human immunodeficiency virus infection. Ann Neurol 1988, 23:519-522.
39. Navia BA, Price RW The acquired immunodeficiency syndrome dementia as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 1987, 44:65-69.
40. Parisi A, DiPerri G, Strosselli M, Cairoli S, Minoli L Instrumental evidence of zidovudine effectiveness in the treatment of HIV-associated subacute encephalitis. AIDS 1988, 2:482-483.
41. Halevie-Goldman BD, Potkin SG, Poyourow P AIDS-related complex presenting as psychosis. Am J Psychiatry 1988, 144:7.
42. Nurnberg HG, Prudic J, Fiori M, Freedman EP Psychopathology complicating acquired immune deficiency syndrome (AIDS). Am J Psychiatry 1984, 141:95-96.
43. Perry SW, Tross S Psychiatric problems of AIDS in patients at the New York Hospital: preliminary report. Pub Health Rep 1984, 99:200-205.
44. Dilley JW, Ochitill HN, Perl M, Volberding PA Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. Am J Psychiatry 1985, 142:87-96.
45. Polan HJ, Hellerstein D, Amchin J Impact of AIDS-related cases on an inpatient therapeutic milieu. Hosp Community Psychiatry 1985, 36:173-176.
46. Price WA, Forejt J Neuropsychiatric aspects of AIDS: A case report. Gen Hosp Psychiatry 1986, 8:7-10.
47. Ostrow D, Grant I, Atkinson H Assessment and management of the AIDS patient with neuropsychiatric disturbances. J Clin Psychiatry 1988, 49:14-22.
48. Cummings JL, Benson F Subcortical dementia: Review of an emerging concept. Arch Neurol 1984, 41:874-879.
49. Kermani E, Drob S, Alpert M Organic brain syndrome in three cases of acquired immune deficiency syndrome. Comp Psychiaty 1984, 25:294-297.
50. Hoffman RS Neuropsychiatric complications of AIDS. Psychosomatics 1984, 25:393-400.
51. Kleihues P, Lang W, Burger PC, Budka H, Vogt M, Maurer R, Luthy R, Siegenthaler W Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1985, 68:333-339.
52. Levy RM, Bredesen DE, Rosenblum ML Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J Neurosurg 1985, 62:475-495.
53. Navia BA, Jordan BD, Price RW The AIDS dementia complex. Ann Neurol 1986, 19:517-524.
54. Beresford TP, Blow FC, Hall RCW AIDS encephalitis mimicking alcohol dementia and depression. Biol Psychiatry 1986, 21:394-397.
55. Navia BA, Jordan BD, Price RW The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 109:517-524.
56. Navia BA, Cho BS, Petito CK, Price RW The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535.
57. Price RW, Brew BJ The AIDS dementia complex. J Infect Dis 1988, 158:1079-1083.
58. Levy RM, Bredesen DE Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acq Immune Def Syn 1988, 1:41-64.
59. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P The brain in AIDS: Central nervous system HIV-1 infection and the AIDS dementia complex. Science 1988, 239:586-592.
60. Tross S, Price RW, Navia B, Thaler HT, Gold J, Hirsch DA, Sidti JJ Neuropsychological characterization of the AIDS dementia complex: A preliminary report. AIDS 1988, 2:81-88.
61. Milner GL Organic reaction in AIDS. Br J Psychiatry 1989, 154:255-257.
62. Ho DD, Bredesen DE, Vinters HV, Daar ES The acquired immunodeficiency syndrome (AIDS) dementia-complex. Ann Intern Med 1989, 111:400-410.
63. Perry SW Organic mental disorders caused by HIV: Update on early diagnosis and treatment. Am J Psychiatry 1990, 147:696-710.
64. Westreich L AIDS dementia complex for the primary physician. Resid Staff Physician 1990, 36:47-53.
65. Holmes VF Treatment of monosymptomatic hypochondriacal psychosis with pimozide in an AIDS patient. Am J Psychiatry 1989, 146:554-555.
66. Halstead S, Riccio M, Harlow P, Oretti R, Thompson C Psychosis associated with HIV infection. Br J Psychiatry 1988, 153:618-623.
67. Buhrich N, Cooper DA, Freed E HIV infection associated with symptoms indistinguishable from functional psychosis. Br J Psychiatry 1988, 152:619-653.
68. Harris MJ, Jeste DV, Gleghorn A, Sewell DD New onset psychosis in HIV-infected patients. J Clin Psychiatry 1991, 52:369-376.
69. Rundell JR, Wise MG, Ursano RJ Three cases of AIDS-related psychiatric disorders. Am J Psychiatry 1986, 143:777-778.
70. Price WA, Forejt J Neuro-psychiatric aspects of AIDS: A case report. Gen Hosp Psychiatry 1986, 8:7-10.
71. Kermani EJ, Borod JC, Brown PH, Tunnell G New psychopathologic findings in AIDS. J Clin Psychiatry 1985, 46:240-241.
72. Gabel RH, Barnard N, Norko M, O'Connell RA AIDS presenting as mania. Compr Psychiatry 1986, 27:251-254.
73. Johannesen DJ, Wilson LG Mania with cryptococcal meningitis in two AIDS patients. J Clin Psychiatry 1988, 49:200-201.
74. Maxwell S, Scheftner WA, Kessler HA, Busch K Manic syndrome associated with zidovudine treatment. JAMA 1988, 259:3406-3407.
75. Centers for Disease Control, and Prevention: HIV/AIDS surveillance report 1999. Atlanta, Georgia U.S. Department of Health and Human Service 11 (no. 1), 1-43.
76. Sporer KA Acute heroin overdose. Ann Intern Med 1999, 130:584-590.
77. Hser Y, Hoffman V, Grella CE, Anglin MD A 33-year followup of narcotics addicts. Arch Gen Psychiatry 2001, 58:503-508.
78. Darke S, Zador D Fatal heroin overdose: a review. Addiction 1996, 91:1765-1772.
79. Cohen MA, Jacobson JM Maximizing life's potentials in AIDS: A psychopharmacologic update. Gen Hosp Psychiatry 2000, 22:375-388.
80. Cohen MA, Alfonso CA Psychiatric care and pain management of persons with HIV infection. AIDS and other manifestations of HIV infection 1998, 475-503. Lippincot-Raven Publishers, Washington, D.C. 3rd ed. G.P. Wormser (Ed.).
81. Cohen MAA Psychodynamic psychotherapy in an AIDS nursing home. J Am Acad Psychoanal 1999, 27:121-133.
82. Dodds S, Blaney NT, Nuehring EM, Blakley T, Lizzotte JM, Potter JE, O'Sullivan MJ Integrating mental health services into primary care for HIV-infected pregnant and non-pregnant women: Whole Life - a theoretically derived model for clinical and outcomes assessment. Gen Hosp Psychiatry 2000, 22:251-260.
83. Smyth JM, Stone AA, Hurewitz A, Kaell A Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis - a randomized trial. JAMA 1999, 281:1304-1309.
84. Holland JC, Passik S, Kash KM, Russak SM, Gronert MK, Sison A, Lederberg M, Fox B, Baider L The role of religious and spiritual beliefs in coping with malignant melanoma. Psycho-Oncology 1999, 8:14-26.
85. Baider L, Russak SM, Perry S, Kash K, Gronert M, Fox B, Holland J, Kaplan-Denour A The role of religious and spiritual beliefs in coping with malignant melanoma: an Israeli sample. Psycho-Oncology 1999, 8:27-35.
86. Moadel A, Morgan C, Fatone A, Grennan J, Carter J, Laruffa G, Skummy A, Dutcher J Seeking meaning and hope: self-reported spiritual and existential needs among an ethnically-diverse cancer patient population. Psycho-Oncology 1999, 8:378-385.
87. Feher S, Maly RC Coping with breast cancer in later life: the role of religious faith. Psycho-Oncology 1999, 8:408-416.
88. Mytko JJ, Knight SJ Body, mind and spirit: towards the integration of religiosity and spirituality in cancer quality of life research. Psycho-Oncology 1999, 8:439-450.
89. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP Naltrexone in the treatment of alcohol dependenc. Arch Gen Psychiatry 1992, 49:876-880.
90. Volpicelli JR, Clay KL, Watson NT, O'Brien CP Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry 1995, 56:39-44.
91. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992, 49:881-887.
92. O'Malley SS, Jaffe AJ, Chang G Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996, 53:217-224.
93. Washton AM, Pottash AC, Gold MS Naltrexone in addicted business executives and physicians. J Clin Psychiatry 1984, 45:39-41.
94. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989, 46:117-121.
95. Ziedonis DM, Kosten TR Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs 1991, 23:417-425.
96. Levin FR, Lehman AF Meta-analysis of desipramine: an adjunct in treatment of cocaine addiction. J Clin Pharmacol 1991, 11:374-378.
97. Nunes EV, Quitkin FM, Brady R, Stewart JW Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use. Am J Psychiatry 1991, 148:667-669.
98. Halikas JA, Crosby RD, Pearson VL, Graves NM A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clin Pharmacol Ther 1997, 62:89-105.
99. Brady KT, Sonne SC, Anton R, Ballenger JC Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 1995, 56:118-121.
100. Markowitz JS, Finkenbine R, Myrick H, King L, Carson WH Gabapentin abuse in a cocaine user: implications for treatment?. J Clin Psychopharmacol 1997, 17:423-424.
101. Chattrerjee CR, Ringold AL A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin. J Clin Psychiatry 1999, 60:617.
102. Myrick H, Malcolm R, Brady K Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 1998, 155:1632.
103. Rosenbaum JF, Fredman SJ Pramipexole treatment for cocaine cravings. Am J Psychiatry 1999, 156:1834.
104. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharm 1995, 15:163-174.
105. Margolin A, Kosten T, Petrakis I, Avants SK, Kosten T Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry 1991, 48:1.
106. Margolin A, Kosten T, Petrakis I, Avants SK, Kosten T Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry 1991, 48:87.
107. Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, Ascher JA, Li SH, Bridge P A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 1995, 40:125-131.
108. Booth RE, Crowley J, Zhang Y Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend 1996, 42:11-20.
109. Cornish JM, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O'Brien CP Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subs Abuse Treatment 1997, 14:529-534.
110. Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, DePhilippis D, Stolley P, Abrutyn E Human immunodefiency virus seroconversion among intravenous drug users in and out of treatment: an 18-month prospective followup. J Acquir Immune Def Syndr 1993, 6:1049-1056.
111. Svikis DS, Golden AS, Huggin GR, Pickens RW, McCaul ME, Velez ML, Rosendale CT, Brooner RK, Gazaway PM, Stitzer ML, Ball CE Cost effectiveness of treatment for drug abusing pregnant women. Drug Alcohol Depend 1997, 45:105-113.
112. Iribarne C, Dréano Y, Bardou LG, Ménez JF, Berthou F Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 1997, 117:13-23.
113. Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune P, Ménez JF Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 1996, 9:365-373.
114. Tseng AL, Foisy MM Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother 1999, 33:461-473.
115. Eagling VA, Back DJ, Barry MG Differential inhibitors of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol 1987, 44:190-194.
116. Gonzalez A, Everall IP Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS 1998, 12:2365-2367.
117. Piscitelli SC, Gallicano KD Interactions among drugs for HIV and opportunistic infections. NEJM 2001, 344:984-996.
118. Gerber JG, Rhodes RJ Cytochrome P450 2B6 (CYP2B6) metabolizes methadone (M) preferentially and stereospecifically: an explanation of drug interaction with antiretroviral drugs. Final program of the first international workshop on clinical pharmacology of HIV therapy 2000, 14. March 30-31, (Abst.).
119. Gerber JG, Gal J, Rosenkranz S, Segal Y, Aberg D, D'Amico R, Mildvan D, Gulick R, Hughes V, Flexner C, Aweeka F, Hsu A, Gal J The effect of ritonavir (RTV)/saquinavir (SQV) on stereoselective pharmacokinetics (PK) of methadone (M): results of AIDS Clinical Trials Group (ACTG) 401. J Acquir Immune Def Syndr 2001, 27:153-160.
120. Lillibridge JH, Liang BH, Kerr BM, Webber S, Quart B, Shetty BV, Lee CA Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. Drug Metab Dispos 1998, 26:609-616.
121. McCance-Katz EF, Farber S, Selwyn PA, O'Connor A Decrease in methadone levels with nelfinavir mesylate. Am J Psychiatry 2000, 157:481.
122. Cobb M, Desai J, Brown LS, Zannikos P, Trapnell C, Rainey P The effect of fluconazole on the clinical pharmacokinetics of methadone. Abstracts of XI International Conference on AIDS 1996, 88. July 7-12:(Abst. Mo. B. 1196), Vancouver, Canada.
123. Williamson PA, Foreman KJ, White JM, Anderson G Methadonerelated overdose deaths in south Australia 1984-1994. Med J Aust 1997, 166:302-305.
124. Raistrick D, Hay A, Wolff K Methadone maintenance and tuberculosis treatment. Br Med J 1996, 313:925-926.
125. Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P Mood and cognitive side effects of interferon-alfa therapy. Semin Oncol 1998, 25(Suppl. 1):39-47.
126. Janssen HLA, Brouwer JT, van der Mast RC, Schalm SW Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994, 21:241-243.
127. Musselman DL, Lawson DH, Gunnick JF, Manatunger AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH Paroxetine for the prevention of depression induced by high-dose interferonalfa. NEJM 2001, 344:961-966.
128. Mao J, Chen LL Gabapentin in pain management. Anesth Analg 2000, 91:680-687.
129. Hemstreet B, Lapointe M Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy. Clin Ther 2001, 23:520-531.
130. Braverman DL, Slipman CW, Lenrow DA Using gabapentin to treat failed back surgery syndrome caused by epidural f. A report of 2 cases. Arch Phys Med Rehabil 2001, 82:691-693.
131. Carter GT, Galer BS Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001, 12:447-459.
132. Schmader K Herpes zoster in older adults. Clin Infect Dis 2001, 32:1481-1486.
133. Dallocchio C, Buffa C, Mazzarello P, Chiroli S Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Sympt Manage 2000, 20:280-285.
134. Chandler A, Williams JE Gabapentin, and adjuvant treatment for neuropathic pain in a cancer hospital. J Pain Sympt Manage 2000, 20:82-86.
135. Nicholson B Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000, 101:359-371.
136. Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler 2000, 6:192-193.
137. Backonja MM Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain 2000, 16:S67-S72. (2 Suppl.).
138. Watson CP The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain 2000, 16:S49-S55. (2 Suppl.).
139. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000, 91:185-191.
140. Laird MA, Gidal BE Use of gabapentin in the treatment of neuropathic pain. Ann Pharmacother 2000, 34:802-807.
141. Swindells S, Zheng J, Gendelman HE HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDS 1999, 13:153-163.
142. Xiong H, Zheng J, Thylin M, Gendelman HE Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res Hum Retroviruses 1999, 15:57-63.
143. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Swindells S Suppression of inflammatory neurotoxins by highly active antiretroviral therapy. Human immunodeficiency virus-associated dementia. J Infect Dis 1998, 178:1000-1007.
144. McEvoy JP Organic brain syndromes. Ann Intern Med 1981, 95:212-220.
145. Lipowski ZJ Delirium, clouding of consciousness and confusion. J Nerv Ment Dis 1967, 145:227-255.
146. Lipowski ZJ Organic mental disorders: introduction and review of syndromes. Comprehensive textbook of psychiatry 1980, 1359-1392. Williams and Wilkins, Philadelphia. 3rd ed. H.I. Kaplan, A.M. Freedman, B.J. Sadock (Eds.).
147. Romano J, Engel GL, Delirium I Electroencephalographic data. Arch Neurol Psychiatry 1944, 51:227-255.
148. Pro JD, Wells CE The use of the electroencephalogram in the diagnosis of delirium. Dis Nerv Syst 1977, 38:807-808.
149. Obrecht R, Okhominia FOA, Scott DF Value of EEG in acute confusional states. J Neurol Neurosurg Psychiatry 1970, 42:75-77.
150. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JP Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Intern Med 1983, 14:403-418.
151. Holland JC, Tross S The psychosocial and neuropsychiatric sequelae of the acquired immunodeficiency syndrome and related disorders. Ann Intern Med 1985, 103:760-764.
152. Parisi A, DiPerri G, Stroselli M, Nappi G, Minoli L, Rondanelli EG Usefulness of computerized electroencephalography in diagnosing, staging, and monitoring AIDS-dementia complex. AIDS 1989, 3:209-223.
153. Koralnik IJ, Beaumanoir A, Hausler R, Kohler A, Safran AB, Delacoux R, Vibert D, Mayer E, Burkhard P, Nahory A, Magistris MR, Sanches J, Myers P, Paccolat F, Quoex F, Gabriel V, Perrin L, Mermillod B, Gauthier G, Waldvogel FA, Hirschel B A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med 1990, 323:864-870.
154. Lipowski ZJ The concept and psychopathology of dementia. Psychosomatic Medicine and Liaison Psychiatry 1985, 307-313. Plenum, Baltimore. Z.J. Lipowski (Ed.).
155. Loewenstein RJ, Sharfstein SS Neuropsychiatric aspects of acquired immune deficiency syndrome. Int J Psychiatry Med 1984, 13:255-260.
156. Goldstein K Functional disturbances in brain damage. American handbook of psychiatry 1975, 182-207. Basic Books, New York. S. Arieti, M.F. Reiser (Eds.).
157. Pfeiffer E A short portable mental status questionnaire for the assessment of organic brain deficits in elderly patients. J Am Geriatr Soc 1975, 23:433-441.
158. Folstein MF, Folstein SE, McHugh PR Mini-mental state - a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
159. Jacobs JN, Bernhard MR, Delgado A, Strain JJ Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977, 86:40-46.
160. Jones BN, Teng EL, Folstein MF A new bedside test of cognition for patients with HIV infection. Ann Intern Med 1993, 119:1001-1004.
161. Power C, Selnes OA, Grim JA, McArthur JC HIV dementia scale: A rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1992, 8:273-278.
162. Cohen MA, Aladjem AD, Brenin D, Ghazi M Firesetting by patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990, 112:386-387.
163. Alfonso CA, Cohen MA HIV dementia and suicide. Gen Hosp Psychiatry 1994, 16:45-46.
164. Ciesla MA, Roberts JE Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001, 158:725-730.
165. Lyketsos CG, Treisman GJ Mood disorders in HIV infection. Psychiatric Ann 2001, 31:45-49.
166. Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ Psychiatric morbidity on entry to an HIV primary care clinic. AIDS 1996, 10:1033-1039.
167. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Study. Am J Psychiatry 1996, 153:1430-1437.
168. Lyketsos CG, Hoover DR, Guccione M Depression and survival among HIV-infected persons. JAMA 1996, 275:35-36.
169. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999, 13:1763-1769.
170. Lyketsos CG, Schwartz J, Fishman M, Treisman G AIDS mania. J Neuropsychiatry Clin Neurosci 1997, 9:277-279.
171. Lyketsos CG, Hanson AL, Fishman M, Rosenblatt A, McHugh PR, Treisman GJ Manic syndrome early and late in the course of HIV. Am J Psychiatry 1993, 150:326-327.
172. Thienhaus OJ, Khosla N Meningeal cryptococcosis misdiagnosed as a manic episode. Am J Psychiatry 1984, 141:1459-1460.
173. Wright JM, Sachdev PS, Perkins RJ, Rodriguez P Zidovudine-related mania. Med J Aust 1989, 150:339-341.
174. Blanch J, Corbella B, Garcia F, Parellada E, Gatell JM Manic syndrome associated with efavirenz overdose. Clin Infect Dis 2001, 33:270-271.
175. Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry 1998, 59:426-429.
176. Armon C, Shin C, Milber P, Carwile S, Brown E, Edinger JD, Paul RG Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996, 47:626-635.
177. Onofrj M, Thomas A, Paci C Reversible parkinsonism induced by prolonged treatment with valproate. J Neurol 1998, 245:794-796.
178. Karas BJ, Wilder EJ, Bauman AW Valproate tremors. Neurology 1982, 32:428-432.
179. Goldstein BJ, Goodnick PJ Selective serotonin reuptake inhibitors-II. Tolerability, safety and pharmacoeconomics. J Psychopharmacology 1998, 12(Suppl. B):555-587.
180. De Battista C, Schatzberg AF Current psychotropic dosing and monitoring guidelines. Primary Psychiatry 2000, 7:26-64.
181. Gelenberg AJ Citalopram (Celexa): SSRI No. 5. Biological Therapies in Psychiatry Newsletter 1998, 2:41-42.
182. Richelson E Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc 1997, 72:835-837.
183. Ferrando SJ, Goldman JD, Charness WE Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS: improvement in affective and somatic symptoms. Gen Hosp Psychiatry 1997, 19:89-97.
184. Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L, Rampello L Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 1998, 37:93-97.
185. Braconier JH, Paulsen O, Engman K, Widell A Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study. Scand J Infect Dis 1995, 27:325-329.
186. Block SD Assessing and managing depression in the terminally ill patient. Am Intern Med 2000, 132:209-218.
187. Chochinov HM, Wilson KG, Enns M, Lander S Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 1994, 151:537-540.
188. Chochinov HM, Wilson KG, Enns M, Lander S "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 1997, 154:674-676.
189. Masand PS, Tesar GE Use of stimulants in the medically ill. Psychiatr Clinics North Am 1986, 19:515-547.
190. Fernandez F, Adams F, Holmes VF, Levy JK, Neidhart M Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Psychosomatics 1987, 28:455-462.
191. Masand P, Pickett P, Murray GB Psychostimulants for secondary depression in medical illness. Psychosomatics 1991, 32:203-208.
192. Fernandez F, Adams F, Levy JK, Holmes VF, Neidhart M, Mansell PW Cognitive impairment due to AIDS-related dementia complex and its response to psychostimulants. Psychosomatics 1988, 29:38-46.
193. Angrist B, d'Hollosy M, Sanfilipo M, Satriano J, Diamond G, Simherkoff M, Weinreb H Central nervous system stimulants as symptomatic treatment for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol 1992, 12:268-272.
194. Wirshing WC, Wirshing DA, Spellberg B, Amanios T Atypical antipsychotics in schizophrenia. Directions Psychiatry 1998, 18:403-422.
195. Baldwin D, Fineberg N, Montgomery S Fluoxetine, fluvoxamine and extrapyramidal tract disorders. Int Clin Psychopharmacol 1991, 6:51-58.
196. Hutton HE, Treisman GJ, Hunt WR, Fishman M, Kendig N, Swetz A, Lyketsos CG HIV risk behaviors and their relationship to posttraumatic stress disorder among women prisoners. Psychiatric Serv 2001, 52:508-513.
197. Allers CT, Benjack KJ Connection between childhood abuse and HIV infection. J Counsel Develop 1991, 70:309-313.
198. Lodico MA, DiClemente RJ The association between childhood sexual abuse and prevalence of HIV-related risk behaviors. Clin Pediatr 1994, 33:498-502.
199. Wingood GM, DiClemente RJ Child sexual abuse, HIV sexual risk, and general relations of African-American women. Am J Prev Med 1997, 13:380-384.
200. Lenderking WR, Wold C, Mayer KH, Goldstein R, Losina E, Seage GR Childhood sexual abuse among homosexual men - Prevalence and association with unsafe sex. J Gen Intern Med 1997, 12:250-253.
201. Lyketsos CG, Fishman M, Hutton H, Cox T, Hobbs S, Spoler C, Hunt W, Driscoll J, Treisman G The effectiveness of psychiatric treatment for HIV-infected patients. Psychosomatics 1997, 38:423-432.
202. Ruiz P Living and dying with HIV/AIDS: a psychosocial perspective. Am J Psychiatry 2000, 157:110-113.
203. Roth AJ, Kornblith AB, Batel-Copell L, Peabody E, Scher HI, Holland JC Rapid screening for psychological distress in men with prostate carcinoma. Cancer 1998, 82:1904-1908.
204. Cohen MAA, Hoffman RG, Pierre-Louis C, Schmeidler J, Carrera G, Ebrahim F, Endor F, Jacobson JM, Alfonso CA Screening for distress, anxiety, and depression in persons with H IV. Psychosomatics 2001, 42:192-193.
205. Cohen MA, Cohen SC AIDS education and a volunteer training program for medical students. Psychosomatics 1991, 32:187-190.
206. Bowles LT The AIDS epidemic (editorial). J Med Educ 1987, 62:541.
207. Bowen OR The war against AIDS. J Med Educ 1987, 62:543-548.
208. Kelly JA, St.Lawrence JS, Smith S, Hood HV, Cook DJ Medical students' attitudes toward AIDS and homosexual patients. J Med Educ 1987, 2:549-556.
209. Goldman JD An elective seminar to teach first-year students the social and medical aspects of AIDS. J Med Educ 1987, 62:557-561.
210. Whalen JP Participation of medical students in the care of patients with AIDS. J Med Educ 1987, 62:53-54.
211. Cooke M, Sande MA The HIV epidemic and training in internal medicine. N Engl J Med 1989, 321:1334-1337.
212. Subcommittee on evaluation of humanistic qualities in the internist American Board of Internal Medicine. Evaluation of humanistic qualities in the internist. Ann Intern Med 1983, 99:720-724.
213. Friedland G AIDS and compassion. JAMA 1988, 259:2898-2899.
214. Cohen MAA, Aladjem A, Horton A, Lima J, Palacios A, Hernandez I, Lefer J, Mehta P How can we combat excess mortality in Harlem: A one-day survey of substance abuse in adult general care. Int J Psychiatry Med 1991, 231:369-378.
215. Goldberg RJ, Daily J, Backstrom D Psychiatric complications and comorbidities in medical patients: The inadequacy of attestation at discharge. Gen Hosp Psychiatry 1996, 18:102-105.
216. Prochaska JO, Norcross JC, Di Clemente CC Changing for good 1995, Avon Books, New York.
217. Hart GJ, Carvell AL, Woodward N, Johnson AM, Williams P, Parry JV Evaluation of needle exchange in central London: behavior change and anti-HIV status over one year. AIDS 1989, 3:261-265.
218. Van Haastrecht HJA, van den Hoek JAR, Bardoux C, Leentvaar-Kuypers A, Coutinho RA The course of the H IV epidemic among intravenous drug users in Amsterdam, The Netherlands. Am J Public Health 1991, 81:59-62.
219. Robertson JR, Bucknall AB, Welsby PD, Roberts JJ, Inglis JM, Peutherer JF, Brettle RP Epidemic of AIDS related virus (HTLVIII/LAV) infection among intravenous drug abusers. Br Med J 1986, 292:527-529.
220. van den Hoek JAR, Coutinho A, van Haastrecht HJA, van Zadelhoff AW, Goudsmit J Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988, 2:55-60.
221. Conviser R, Rutledge JH Can public policies limit the spread of HIV among IV drug users?. J Drug Issues 1989, 19:113-128.
222. Buning EC, Hargers C, Verster AD, van Santen GW, Coutinho RA The evaluation of the needle/syringe exchange in Amsterdam. IVth International Conference on AIDS 1988, 8513. (abst.).
223. Des Jarlais DC, Hagan H, Purchase D, Reid T, Friedman SR Safer injection among participants in the first North American syringe exchange program. Vth International Conference on AIDS 1989, TAO20 (abst.).
224. Jones LD Working with drug users to prevent the spread of HIV: The application of an analytical framework to a range of programmes. Health Educ Res 1990, 5:5-16.
225. Joseph SC Current challenges of AIDS in New York City. NY State J Med 1989, 89:517-519.
226. Goldberg D, Watson H, Stuart F, et al. Pharmacy supply of needles and syringes-the effect on spread of HIV intravenous drug misusers. IVth International Conference on AIDS, Stockholm. Sweden. 1988, 8521. (abst.).
227. McKeganey N, Barnard M, Watson H HIV-related risk behavior among a non-clinic sample of injecting drug users. Br J Addict 1989, 84:1481-1490.
228. Des Jarlais DC, Hopkins W "Free" needles for intravenous drug users at risk for AIDS: Current developments in New York City. N Engl J Med 1985, 313:1476.
229. De Buono BA, Zinner SH, Daamen M, McCormack WM Sexual behavior of college women in 1975, 1986 and 1989. N Engl J Med 1990, 322:821-825.
230. MacDonald NE, Wells GA, Fisher WA, Warren WK, King MA, Doherty JA, Bowie WR High-risk STD/HIV behavior among college students. JAMA 1990, 263:3155-3159.
231. Cochran SD, Mays VM Sex, lies and HIV. N Engl J Med 1990, 22:774-775.
232. Reinisch JM, Beasley R America fails sex information test. The Kinsey Institute new report on sex: What you must know to be sexually literate 1990, 1-26. St. Martin's Press, New York.
233. Nichols SE The social climate when AIDS developed. Psychiatric implications of acquired immune deficiency syndrome 1984, 85-92. American Psychiatric Press, New York. S.E. Nichols, D.G. Ostrow (Eds.).
234. Cassens B Social consequences of acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:768-771.
235. Nichols SE Psychosocial reactions of persons with the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:765-767.
236. Rabkin JG, Remien R, Katoff L, Williams JB Suicidality in AIDS long-term survivors: What is the evidence?. AIDS Care 1985, 5:401-411.
237. Glass RM AIDS and suicide. JAMA 1988, 259:1369-1370.
238. O'Dowd MA, McKegney FP AIDS patients compared with others seen in psychiatric consultation. Gen Hosp Psychiatry 1990, 12:50-55.
239. Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatric Serv 2000, 51:903-907.
240. Chandra PS, Ravi V, Desai A, Subbakrishna DK Anxiety and depression among HIV-infected heterosexuals - a report from India. J Psychosom Res 1998, 45:401-409.
241. Sindiga I, Lukhando M Kenyan university students' views on AIDS. East Afr Med J 1993, 70:713-716.
242. Kelly B, Raphael B, Judd F, Perdices M, Kernutt G, Burnett P, Dunne M, Burrows G Suicidal ideation, suicide attempts, and HIV infection. Psychosomatics 1998, 39:L405-L415.
243. Blumenthal SJ Suicide: A guide to risk factors, assessment, and treatment of suicidal patients. Med Clin North Am 1988, 72:937-971.
244. Harris EC, Barraclough BM Suicide as an outcome for medical disorders. Medicine 1994, 73:281-296.
245. McHugh PR Suicide and medical afflictions. Medicine 1994, 73:297-298.
246. Abram HS, Moore GL, Westervelt FB Suicidal behavior in chronic dialysis patients. Am J Psychiatry 1971, 127:119-124.
247. Breitbart W Suicide in cancer patients. Oncology (Huntingt) 1987, 4:49-54.
248. Farberow L, McKelligott JW, Cohen S, Darbonne A Suicide among patients with cardiorespiratory illnesses. JAMA 1966, 195:422-428.
249. Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1984, 47:1283-1287.
250. Rundell JR, Wise ME, Ursano RJ Three cases of AIDS-related psychiatric disorders. Am J Psychiatry 1986, 143:777-778.
251. Pierce C Underscore urgency of HIV counseling: Several suicides follow positive tests. Clin Psychiatry News 1987, October 1.
252. Brown GR, Rundell JR Suicidal tendencies in women with human immunodeficiency virus infection. Am J Psychiatry 1989, 146:556-557.
253. Gutierrez R, Atkinson H, Velin R, Patterson T, Heaton R, Grant I, Smith K, Pace P, Weinrich J Coping and neuropsychological correlates of suicidality in HIV. VIth International Conference on AIDS. San Francisco. 1990, 6:182. (abst.).
254. Ritchie EC, Radke AQ, Ross B Depression and support systems in male army HIV+ patients. Mil Med 1992, 157:345-349.
255. Rundell JR, Kyle KM, Brown GR, Thomason JL Risk factors for suicide attempts in a human immunodeficiency virus screening program. Psychosomatics 1992, 33:24-27.
256. Pugh K, O'Donnell I, Catalan J Suicide and HIV disease. AIDS Care 1993, 5:391-400.
257. Urban T, Chouaid C, Febvre M, Roussard P, Housset B, Lebeau B Mercury pulmonary embolism after voluntary injection. Rev Mal Respir 1993, 10:477-479.
258. Copeland AR Suicide among AIDS patients. Med Sci Law 1993, 33:21-28.
259. Zomitta M, Bastos C, de Siqueira VH Suicidal risk of AIDS patients: Importance of psychological intervention. Xth International Conference on AIDS, Yokohoma, Japan. 1994, 10:394. (abst.).
260. Hasan MA, Farag AB, Elkerdawi MM Human rights of HIV-infected persons/PWAS in Egypt. Xth International Conference on AIDS, Yokohama, Japan. 1994, 10:418. (abst.).
261. Frierson RL, Lippmann SB Suicide and AIDS. Psychosomatics 1988, 29:226-231.
262. Marzuk PM, Tierney H, Tardiff K, Gross EM, Morgan EB, Hsu MA, Mann JJ Increased risk of suicide in persons with AIDS. JAMA 1988, 259:1333-1337.
263. Kizer KW, Green M, Perkins CI, Doebbert G, Hughes MJ AIDS and suicide in California. JAMA 1988, 260:1881.
264. Plott RT, Benton SD, Winslade WJ Suicide of AIDS patients in Texas: A preliminary report. Tex Med 1989, 85:40-43.
265. Coté TR, Biggar RJ, Dannenberg AL Risk of suicide among persons with AIDS. JAMA 1992, 268:2066-2068.
266. Rajs J, Fugelstad A Suicide related to human immunodeficiency virus infection in Stockholm. Acta Psychiatr Scand 1992, 85:234-239.
267. Reardon J, Wise F, Hart J, Keilch R, Warren N, Brunner W, Ruiz J HIV infection and violent death (homicides/suicides). Contra Costa County, California. (1994). Xth International Conference on AIDS, Yokohama, Japan. 1990-1993, 20:244. (abst.).
268. McCreary C, Pilkington R, Bergin C, Walsh J, Mulchay F Non-HIV-related deaths in the Irish HIV population. International Conference on AIDS 1993, 9:789. (abst.).
269. Ndimbie OK, Perper JA, Kingsley L, Harty L, Winkelstein A Sudden unexpected death in a male homosexual cohort. Am J Forensic Med Pathol 1994, 15:247-250.
270. Marzuk PM, Tardiff K, Leon AC, Hirsch CS, Hartwell N, Portera L, Iqbal MI HIV seroprevalence among suicide victims in New York City, 1991-1993. Am J Psychiatry 1997, 154:1720-1725.
271. Cohen MA, Merlino JP The suicidal patient on the surgical ward: Multidisciplinary case conference. Gen Hosp Psychiatry 1983, 5:65-71.
272. Sabbath J The suicidal adolescent: The expendable child. J Am Acad Child Psychiatry 1969, 8:272-289.
273. Beck AT, Steer RA, Kovacs M, Garrison B Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 1985, 142:559-563.
274. Miles CP Conditions predisposing to suicide: A review. J Nev Ment Dis 1977, 164:231-246.
275. Barraclough B, Bunch J, Nelson B, Sainsbury P A hundred cases of suicide: clinical aspects. Br J Psychiatry 1974, 25:355-372.
276. Leibenluft E, Goldberg RL The suicidal terminally ill patient with depression. Psychosomatics 1988, 29:379-386.
277. Guze SB, Robins E Suicide and primary affective disorder. Br J Psychiatry 1970, 117:437-438.
278. Marzuk PM, Tardiff K, Leon AC, Stajic M, Morgan EB, Mann JJ Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. Am J Psychiatry 1992, 149:371-375.
279. Roy A Suicide in schizophrenia. Suicide 1986, 97-112. Williams & Wilkins, Washington, D.C. A. Roy (Ed.).
280. Frances A Personality and suicide. Ann NY Acad Sci 1986, 487:281-293.
281. Huntington G On Chorea. Med Surg Reporter 1872, 26:317-321.
282. Glickman LS The suicidal patient. Psychiatric consultation in the general hospital 1980, 181-202. Dekker, Baltimore. L.S. Glickman (Ed.).
283. Spitz RA Hospitalism: an inquiry into the genesis of psychiatric conditions in early childhood. Psychoanal Study Child 1945, I:53-74.
284. Spitz RA Anaclitic depression. Psychoanal Study Child 1946, 2:313-317.
285. Engel GL A life-setting conducive to illness: The giving-up complex. Ann Intern Med 1968, 69:293-300.
286. Schmale AH Relation of separation and depression to disease I: A report on hospitalized medical population. Psychosom Med 1958, 20:259-277.
287. Hofer M The Parent-Infant Relationship. The roots of human behavior: An introduction to the psychobiology of early development 1981, 193-233. W. H. Freeman, New York.
288. Holmes TH, Rahe RH The social readjustment rating scale. J Psychosom Res 1967, 11:213-218.
289. Rahe RH, Meyer M, Smith M, Kjaer G, Holmes TH Social stress and illness onset. J Psychosom Res 1964, 8:35-44.
290. Weiner H Psychobiological contributions to human disease. Psychobiology and human disease 1977, 575-651. Flsevier/North-Holland, San Francisco.
291. Kanner A, Coyne J, Schaefer C Comparisons of two modes of stress measurement: Daily hassles and uplifts versus major life events. J Behav Med 1981, 4:1-39.
292. Berkman LF, Syme SL Social networks, host resistance, and mortality: A nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979, 109:186-204.
293. Greer S, Morris T, Pettingale KW Psychological response to breast cancer: Effect on outcome. Lancet 1979, 2:785-787.
294. Shekelle RB, Raynor WJ, Ostfeld AM, Garron DC, Bieliauskas LA, Liu SC, Maliza C, Paul O Psychological depression and 17-year-risk of death from cancer. Psychosom Med 1981, 43:117-125.
295. Schleifer SJ, Keller SE, Camerino M, Thornton JC, Stein M Suppression of lymphocyte stimulation following bereavement. JAMA 1983, 250:374-377.
296. Silberstein C Psychobiological considerations in the development of acquired immunodeficiency syndrome. Einstein J Biol Med 1985, 3:136-143.
297. Blumenfield M Letter to the editor. Gen Hosp Psychiatry 1986, 8:217.
298. Fawzy FL, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990, 47:720-725.
299. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, Fahey JL A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 1990, 47:729-735.
300. Derogatis LR, Abeloff MD, Meliasataros N Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 1979, 242:1504-1508.
301. Spiegel D, Bloom J, Yalom ID Group support for patients with metastatic breast cancer. Arch Gen Psychiatry 1981, 38:527-533.
302. Spiegel D, Bloom JR, Kraemer HC, Gottheil E Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2:888-891.
303. Spiegel D Can psychotherapy prolong cancer survival?. Psychosomatics 1990, 31:361-366.
304. Alfonso CA, Cohen MAA The role of group therapy in the care of persons with AIDS. J Am Academy of Psychoanalysis 1997, 25:623-638.
305. Summers J, Robinson R, Capps L, Zisook S, Atkinson JA, McCutchan E, McCutchan JA, Deutsch R, Patterson T, Grant I The influence of H IV-related support groups on survival in women who lived with HIV-a pilot study. Psychosomatics 2000, 41:262-268.
306. Novick DM, Ochshom M, Kreek MJ In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts. Drugs of Abuse, Immunity, and Immunodeficiency 1991, Plenum Press, New York. H. Friedman, S. Specter, T.W. Klein (Eds.).
307. Brown SM, Stimmel B, Taub RN, Kochwa S, Rosenfield RE Immunologic dysfunction in heroin addicts. Arch Intern Med 1974, 14:1001-1006.
308. Novick DM, Ochshorn M, Ghali V, Croxson TS, Mercer WD, Chiorazzi N, Kreek MJ Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Therp 1989, 250:606-610.
309. McDonough RJ, Madden JJ, Falek A, Shafer DA, Pline M, Gordon D, Bokos P, Kuehnle JC, Mendelson J Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 1980, 125:2539-2543.
310. Ochshorn M, Novick DM, Kreek MJ In vitro studies of the effect of methadone on natural killer cell activity. Is J Med Sci 1990, 26:421-425.
311. Bayer BM, Mulroney SE, Hernández MC, Ding XZ Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology 1995, 29:19-28.
312. Jeong TC, Jordan SD, Matulka RA, Stanulis ED, Kaminski EJ, Holsapple MP Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response. J Pharmacol Exp Ther 1995, 272:407-416.
313. Jeong TC, Matulka RA, Jordan SD, Yang KH, Holsapple MP Role of metabolism in cocaine-induced immunosuppression in splenocyte cultures from B6C3F1 female mice. Immunopharmacology 1995, 29:37-46.
314. Pirozhkov SV, Watson RR, Chen GJ Ethanol enhances immunosuppression induced by cocaine. Alcohol 1993, 2:75-82.
315. Nair MP, Schwartz SA, Kronfol ZA, Hill EM, Sweet AM, Greden JF Suppression of tumor necrosis factor production by alcohol in lipopolysaccharide-stimulated culture. Alcohol Clin Exp Res 1994, 18:602-607.
316. Razani-Boroujerdi S, Savage SM, Sopori ML Alcohol-induced changes in the immune response. Toxicol Appl Pharmacol 1994, 127:37-43.
317. Bounds W, Betzing KW, Stewart RM, Holcombe RF Social drinking and the immune response: Impairment of lymphokine-activated killer activity. Am J Med Sci 1994, 307:391-395.
318. Smith SH, Harris LS, Uwaydah IM, Munson AE Structure-activity of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J Pharmacol Exp Ther 1978, 207:165-170.
319. Levy JA, Heppner GH Immunosuppression and its cannabinoid constituents. J Immunopharmacol 1980, 2:159-177.
320. Hollister LE Marijuana and immunity. J Psychoactive Drugs 1992, 24:159-164.
321. Khansar N, Whitten HD, Fudenberg HH Phencyclidine-induced immunodepression. Science 1984, 225:76-78.
322. Jacob CV, Stelzer GT, Wallace JH The influence of cigarette tobacco smoke products on the immune response. Immunology 1980, 40:621-627.
323. Geng Y, Savage SM, Johnson LJ, Seagrave J, Sopori ML Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol Appl Pharmacol 1995, 135:268-278.
324. Fernández F, Holmes VF, Levy JK, Ruiz P Consultation-liaison psychiatry and HIV-related disorders. Hosp Community Psychiatry 1989, 40:146-153.
325. Wolcott DL, Fawzy FL, Pasnau RO Acquired immune deficiency syndrome (AIDS) and consultation-liaison psychiatry. Gen Hosp Psychiatry 1985, 7:280-292.
326. Kearny M, Mount B Spiritual care of the dying patient. Handbook of psychiatry in palliative medicine 2000, Oxford University Press, New York. H. Chochinov, W. Breitbart (Eds.).
327. Saunders C Spiritual Pain. J Palliat Care 1988, 4:29-32.
328. Lunn L Spiritual concerns in palliation. The management of terminal malignant disease 1993, 213-225. Edward Arnold. 3rd ed. C. Saunders (Ed.).
329. Moore T Care of the soul 1992, xi-xiii. Harper Collins, New York.
330. Cassell EJ The nature of suffering and the goals of medicine 1991, 33. Oxford University Press, Oxford.
331. Frank JD The faith that heals. Johns Hopkins Med J 1975, 137:127.
332. Becker E The birth and death of meaning 1972, Free Press. 2nd ed.
333. Jacox AJ, Carr DB, Payne R New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 1994, 330:651.
334. Sison A, Eller KC, Segal J, Passik S, Breitbart W Suicidal ideation in ambulatory HIV-infected patients: the roles of pain, mood, and disease states. Current Concepts in Psycho-oncology IV 1991, Abstract, New York.
335. Rosenfeld B, Breitbart W, McDonald MV, Passik SD, Thaler H, Portenoy RK Pain in ambulatory AIDS patients: impact of pain on physiological functioning and quality of life. Pain 1997, 68:323-328.
336. Breitbart WS, Passik S, Eller KC, Sison A Suicidal ideation in AIDS: The role of pain and mood. 145th Annual Meeting of the American Psychiatric Association 1992, 267. (abst.).
337. Lebovits AH, Smith G, Maignan M, Lefkowitz M Pain in hospitalized patients with AIDS: Analgesic and psychotropic medications. Clin J Pain 1994, 10:156-161.
338. Schofferman J Pain: Diagnosis and management in the palliative care of AIDS. J Palliat Care 1988, 4:46-49.
339. Lebovits AH, Lefkowitz M, McCarthy D, Simon R, Wilpon H, Jung R, Fried E The prevalence and management of pain in patients with AIDS: A review of 134 cases. Clin J Pain 1989, 5:245-248.
340. Lefkowitz M, Lebovits A, Smith G, Maignan M The prevalence and management of pain in patients with AIDS: A second look three years later. VIIIth International Conference on AIDS 1992, PUB 7304 (abst.).
341. Singh S, Fermie P, Peters W Symptom control for individuals with advanced HIV in a subacute residential unit: Which symptoms need palliation?. VIIIth International Conference on AIDS 1992, PoB D428 (abst.).
342. Zarowny D, McCormack J, Li R, Singer J Incidence of pain in ambulatory HIV patients. VIIIth International Conference on AIDS 1991, PoB 3551 (abst.).
343. Singer EJ, Zorilla C, Fahy-Chandon B, Chi S, Syndulko K, Tourtellotte WW Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain 1993, 54:15-19.
344. Reiter GS, Kudler NR Palliative care and HIV: Systemic manifestations and late-stage issues. AIDS Clin Care 1996, 8:27-36.
345. Kimball LR, McCormick WC The pharmacologic management of pain and discomfort in persons with AIDS near the end of life: use of opioid analgesia in hospice setting. J Pain Sympt Manage 1996, 11:88-94.
346. Newshan GT, Wainapel SF Pain characteristics and their management in persons with AIDS. JANAC 1993, 4:53-59.
347. Portenoy RK Chronic pain management. Psychiatric care of the medical patient 1993, Oxford University Press. A. Stoudemire, B.S. Fogel (Eds.).
348. Berne RM, Levy MN The somatosensory system. Physiology 1983, 145-164. The C. V. Mosby Company, New York.
349. Guyton AC Somatic sensations: Pain, visceral pain, headache, and thermal sensations. Textbook of medical physiology 1987, 611-675. W. B. Saunders Company, St. Louis, MO.
350. Snider WD, Simpson DM, Nielson G, Gold JW, Metroka CE, Posner JB Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 1983, 14:403-418.
351. Levy RM, Bredesen DE, Rosenblum ML Neurological manifestations of the acquired immunodeficiency syndrome: Experience at UCSF and review of the literature. J Neurosurg 1985, 62:475-495.
352. Comblath DR, McArthur JC, Griffith JW The spectrum of peripheral neuropathies in HTLV-III infection. Muscle Nerve 1986, 9(Suppl. 76).
353. Comblath DR, McArthur JC Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794-796.
354. Bacellar H, Muñoz A, Miller EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC Temporal trends in the incidence of HIV-1 related neurologic disease: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1984, 44:1892-1900.
355. Husstedt IW, Grotemeyer KH, Busch H, Zidek W Progression of distal-symmetric polyneuropathy in HIV infection: A prospective study. AIDS 1993, 7:1069-1073.
356. Schaumburg HJ, Arezzo J, Berger A, Skowron G, Bozzette S, Soo W Dideoxycytidine (ddC) neuropathy in HIV: A report of 52 patients. Neurology 1990, 40(Suppl. 1):428.
357. Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr 1992, 5:60-64.
358. Petersen E, Ramirez-Ronda C, Schwartz R Findings from a phase II study of stavudine (d4T). VIIIth International Conference on AIDS 1992, (abst.).
359. Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, Soo W 2'.3'-Dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology 1993, 43:358-362.
360. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ Physician attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993, 119:121-126.
361. Forrest WH, Smethurst PWR, Kienitz ME Self-administration of intravenous analgesics. Anesthesiology 1970, 33:363.
362. Hull CJ, Sibbald A Control of postoperative pain by interactive demand analgesia. Br J Anaesth 1981, 53:385.
363. Perry S The undermedication for pain: A psychoanalytic perspective. Bull Assoc Psychoanalytic Med 1983, 77-93. June.
364. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadosi S Correlation of patient and caregiver ratings of cancer pain. J Pain Sympt Manage 1991, 6:53-57.
365. Ferrell BA Pain evaluation and management in the nursing home. Ann Intern Med 1995, 123:681-687.
366. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1944, 330:592-596.
367. Hoyt MJ, Nokes K, Newshan G, Staats JA, Thorn M The effect of chemical dependency on pain perception in persons with AIDS. JANAC 1994, 5:33-38.
368. Larve F, Fontaine A, Colleau SN Underestimation and undertreatment of pain in HIV disease: Multicenter study. BMJ 1997, 314:223-228.
369. Porter J, Jick H Addiction rare in patients treated with narcotics. N Engl J Med 1980, 302:123.
370. Goldberg RJ Acute pain management. Psychiatric care of the medical patient 1993, 323-340. Oxford University Press, Philadelphia. A. Stoudemire, B.S. Fogel (Eds.).
371. World Health Organization Cancer pain relief 1986, Geneva.
372. Lee WM Drug-induced hepatoxicity. N Engl J Med 1995, 333:1118-1127.
373. Jonsson E, Coombs DW, Hunstad D, Richardson JR, von Reyn CF, Saunders RL, Heaney JA Continuous infusion of intrathecal morphine to control acquired immunodeficiency syndrome-associated bladder pain. J Urol 1992, 147:687-689.
374. Geara F, Le Bourgeois JP, Piedbois P, Pavlovitch JM, Mazeron JJ Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1991, 21:1517-1522.
375. Tosches WA, Cohen CJ, Day JM A pilot study of acupuncture for the symptomatic treatment of HIV-associated peripheral neuropathy. VIIIth International Conference on AIDS. Amsterdam, Holland 1992, 8:14. (abst.).
376. Carmichael JK Treatment of herpes zoster and postherpetic neuralgia. Am Fam Physician 1991, 44:203-210.
377. Ruebottom A, Lee C, Dryden PJ Massage therapy for terminally ill AIDS patients. Vth International Conference on AIDS. Montreal. Quebec. Canada 1989, 5:481. (abst.).
378. Teopista N The use of aromatherapy in the management of people with AIDS: The AIDS Support Organization (TASO). Ugandan experience. IXth International Conference on AIDS 1993, 9:497. (abst.).
379. Lampin DL, Abrahamowiez M, Gilmore N, Edgar L A randomized, controlled trial to evaluate a psychosocial intervention to improve quality of life in HIV infection. International Conference on AIDS 1993, 9:777. (abst.).
380. Fawzy FL, Namir S, Wolcott DL Structural group intervention model for AIDS patients. Psychiatr Med 1989, 7:35-45.
381. Kelly JA, Murphy DA, Bahr GR, Kalichman SC, Morgan MG, Stevenson LY, Koob JJ, Brasfield TL, Bernstein BM Outcome of cognitive behavioral and support group brief therapies for depressed HIV-infected persons. Am J Psychiatry 1993, 150:1679-1686.
382. Passik SD, Portenoy RK Substance abuse issues in palliative care. Supportive Oncology 1998, J. B. Lippincott, New York. A. Berger, M. Levy, R.K. Portenoy (Eds.).
383. Ferrando SJ Substance abuse and HIV infection. Psychiatric Ann 2001 2001, 31:57-62.
384. Kurz A, Sessler DI, Lenhardt R Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996, 334:1209-1215.
385. Kaplan SH, Greenfield S, Gandek B, Rogers WH, Ware JE Characteristics of physicians with participatory decision-making styles. Ann Intern Med 1996, 124:497-504.
386. Lipkin M Sisyphus or Pegasus? The physician interviewer in the era of corporatization of care. Ann Intern Med 1996, 124:511-513.
387. Kushner H Religious resources for healing. Proceedings of ASCOA 1996, 73-79.
388. Turnock BJ, Kelly CJ Mandatory premarital testing for human immunodeficiency virus-the Illinois experience. JAMA 1989, 261:3415-3418.
389. Lo B, Steinbrook RL, Cooke M, Coates TJ, Walters EJ, Hulley SB Voluntary screening for human immunodeficiency virus (HIV) infection-weighing the benefits and harms. Ann Intern Med 1989, 110:727-733.
390. Drotman DP Earlier diagnosis of human immunodeficiency virus (HIV) infection and more counseling. Ann Intern Med 1989, 110:680-681.
391. Connor EM Reduction of maternal-infant transmission of HIV type 1 with zidoyudine treatment (ACTGO76). N Engl J Med 1994, 331:1173-1180.
392. Council on Ethical and Judicial Affairs Decisions near the end of life. JAMA 1992, 267:2229-2233. American Medical Association.
393. Creditor MC Hazards of hospitalization of the elderly. Ann Intern Med 1993, 118:219-223.
394. Selik RM, Chu SY, Ward JW Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987-1992. Ann Intern Med 1995, 123:933-936.